百令胶囊辅助缬沙坦治疗IgA肾病及对肾功能、Th1/Th2漂移、尿PCX、B7-1水平的影响

doi:10.3969/j.issn.1000-8535.2023.02.009

广州医药 ›› 2023, Vol. 54 ›› Issue (2): 46-49.DOI: 10.3969/j.issn.1000-8535.2023.02.009

百令胶囊辅助缬沙坦治疗IgA肾病及对肾功能、Th1/Th2漂移、尿PCX、B7-1水平的影响

罗丽¹, 刘中奇², 范予劼²

1 西部战区总医院肾内科(成都 610083)
2 西部战区总医院第三派驻门诊部(成都 610083)

收稿日期:2022-02-28 出版日期:2023-02-20 发布日期:2023-02-27

Effects of Bailing capsules assisting valsartan in the treatment of IgA nephropathy and its influence on renal function, Th1/Th2 drift, urine PCX and B7-1 levels

LUO Li¹, LIU Zhongqi², FAN Yujie²

1 Department of Nephrology, Western Theatre Command General Hospital,Chengdu 610083, China
2 Third Department of Outpatient, Western Theatre Command General Hospital,Chengdu 610083, China

Received:2022-02-28 Online:2023-02-20 Published:2023-02-27

摘要/Abstract

摘要： 目的观察百令胶囊辅助缬沙坦治疗IgA肾病效果及对患者肾功能、细胞免疫调节、尿足细胞标志蛋白的影响。方法选取2019年5月—2021年5月西部战区总医院肾内科收治经肾活检确诊为IgA肾病,筛选治疗方案中尚未使用激素及免疫抑制剂的80例患者,按住院先后顺序随机分为观察组和对照组,每组各40例。对照组给予缬沙坦治疗,观察组给予百令胶囊辅助缬沙坦治疗,治疗12周后,比较2组的疗效、治疗前后肾功能指标[24 h蛋白尿(24 h Upro)、尿素氮(BUN)、血肌酐(SCr)、尿红细胞(RBC)计数]、1型/2型辅助性T细胞(Th1/Th2)代表细胞因子[γ-干扰素(IFN-γ)、白介素-4(IL-4)]、尿足细胞标志蛋白[尿足萼糖蛋白(PCX)、尿足细胞B7-1分子(B7-1)]水平。结果治疗12周后,观察组的治疗总有效率为95.0%,高于对照组的82.5%;观察组的24 h Upro、BUN、SCr、尿RBC计数低于对照组,IFN-γ、Th1/Th2低于对照组、IL-4高于对照组,尿PCX、B7-1水平低于对照组;差异均有统计学意义(P<0.05)。结论百令胶囊辅助缬沙坦治疗IgA肾病患者,可以提高临床疗效,有效保护患者肾功能,调节其免疫状态,减轻肾损伤。

关键词: IgA肾病, 百令胶囊, 缬沙坦, 肾功能

Abstract: Objective To observe the effects of Bailing capsules assisting valsartan in the treatment of IgA nephropathy and its influence on renal function, cellular immune regulation and urine prodocytes marker protein. Methods From May 2019 to May 2021, 80 patients with IgA nephropathy confirmed by renal biopsy in the Nephrology Department of Western Theatre Command General Hospital, who had not used hormones or immunosuppressants in the treatment were selected.Patients were divided into observation group and control group according to the order of hospitalization, 40 cases in each group.The control group was given valsartan, and the observation group was given Bailing capsules and valsartan.After 12 weeks of treatment, the efficacy, the levels of renal function indexes [24 h proteinuria (24 h Upro), urea nitrogen (BUN), serum creatinine (SCr), urinary red blood cell (RBC) count], type 1/type 2 helper T cells (Th1/Th2) represent cytokines [interferon-γ (IFN-γ), interleukin-4 (IL-4)], urine prodocytes marker protein [urine podocalyxin (PCX), urinary podocyte B7-1 molecule (B7-1)] before and after treatment were compared between the two groups. Results After treatment, the total effective rate in observation group was higher than that in control group (95.0% vs 82.5%).The 24 h Upro, BUN, SCr levels and urine RBC count in observation group were lower than those in control group, IFN-γ and Th1/Th2 levels were lower than those in control group, the IL-4 level was higher than that in control group, and the levels of urine PCX and B7-1 were lower than those in control group.Those differences were statistically significant (P<0.05). Conclusions Bailing capsules assisting valsartan in the treatment of IgA nephropathy can improve clinical efficacy, effectively protect the renal function of patients, regulate the immune status, and alleviate renal injury.

Key words: IgA nephropathy, Bailing capsules, valsartan, renal function

罗丽, 刘中奇, 范予劼. 百令胶囊辅助缬沙坦治疗IgA肾病及对肾功能、Th1/Th2漂移、尿PCX、B7-1水平的影响[J]. 广州医药, 2023, 54(2): 46-49.

LUO Li, LIU Zhongqi, FAN Yujie. Effects of Bailing capsules assisting valsartan in the treatment of IgA nephropathy and its influence on renal function, Th1/Th2 drift, urine PCX and B7-1 levels[J]. Guangzhou Medical Journal, 2023, 54(2): 46-49.

参考文献

[1] SHEN J,WU Q,LIANG T, et al.TRIM40 inhibits IgA1-induced proliferation of glomerular mesangial cells by inactivating NLRP3 inflammasome through ubiquitination[J].Mol Immunol,2021(140):225-232.
[2] 郭正勇,许洪涛,冒艳阳,等.缬沙坦联合前列地尔对慢性肾小球肾炎患者血液流变学、尿蛋白及肾功能的影响[J].临床内科杂志,2017,34(6):405-407.
[3] 方辉,张旭环,陈铁霁.缬沙坦氨氯地平联合百令胶囊治疗肾性高血压伴蛋白尿64例分析[J].心脑血管病防治,2017,17(4):310-311.
[4] 周静,魏昕,曾艳,等.氯沙坦钾联合益肾化湿颗粒治疗慢性肾小球肾炎的临床疗效及安全性评价[J].中国临床药理学杂志,2016,32(4):297-299.
[5] 林书典,詹锋,武伟,等.klotho在慢性肾脏病分期及其并发继发性甲状旁腺功能亢进症中的作用[J].中国全科医学,2016,19(3):272-276.
[6] 朱安超,杨鑫鑫,候云晶,等.IgA肾病与微生物免疫的研究进展[J].中国现代医学杂志,2021,31(2):33-37.
[7] 李晓宁,王向荣.复方石韦颗粒联合缬沙坦和前列地尔治疗慢性肾小球肾炎的临床研究[J].现代药物与临床,2016,31(10):1628-1631.
[8] 王亿平,张磊,王东,等.参地颗粒对慢性肾小球肾炎脾肾亏虚证患者T细胞亚群及足细胞标志蛋白的影响[J].中国中西医结合杂志,2017,37(12):1447-1450.
[9] KREBS C F,STEINMETZ O M.CD4 T cell fate in glomerulonephritis: A tale of Th1, Th17, and novel Treg subtypes[J].Mediators Inflamm,2016(2016):5393894.
[10] 张微,熊军,王景平,等.缬沙坦联合前列地尔对慢性肾小球肾炎患者肾功能、免疫指标及其细胞因子的影响[J].疑难病杂志,2017,16(12):1236-1239.
[11] 王加平,孟晓波,李恒星,等缬沙坦联合前列地尔治疗慢性肾小球肾炎的疗效及对肾功能、血流变学、t-PA和PAI-1的影响[J].海南医学,2017,28(24):4036-4039.
[12] 何艳.百令胶囊联合氯沙坦钾治疗慢性肾小球肾炎的临床研究[J].现代药物与临床,2018,33(4):903-907.
[13] 许惠娟,李时悦.百令胶囊的药理作用及其在肺部疾病的研究进展[J].中国中药杂志,2010,35(20):2777-2781.
[14] 周韵娇,李鹏,张丽红,等.慢性肾小球肾炎患者外周血Th1/Th2及CD28细胞的变化及其临床意义[J].检验医学,2015,30(2):141-144.
[15] 杨薪博,吴洁琼,孙杰.肾炎舒联合氯沙坦对早期DN患者尿足细胞及炎症因子的影响[J].西南国防医药,2017,27(10):1068-1071.

百令胶囊辅助缬沙坦治疗IgA肾病及对肾功能、Th1/Th2漂移、尿PCX、B7-1水平的影响

Effects of Bailing capsules assisting valsartan in the treatment of IgA nephropathy and its influence on renal function, Th1/Th2 drift, urine PCX and B7-1 levels

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

本文评价

[1]	李俊. 补阳还五汤加减治疗肾病综合征的疗效及临床价值[J]. 广州医药, 2022, 53(2): 48-51.
[2]	仲小莉, 郭雨淋. 百令胶囊联合前列地尔对早期糖尿病肾病患者血液流变学及肾功能的影响[J]. 广州医药, 2022, 53(2): 68-71.
[3]	罗丽, 郑剑琴. 应用肾衰康方对慢性肾衰竭患者血清微炎症状态的影响及肾功能保护作用的提升研究[J]. 广州医药, 2021, 52(5): 97-100.
[4]	王双艳, 高庆春. 老年慢性肾功能不全继发脑血管疾病头颅MR的研究[J]. 广州医药, 2017, 48(3): 52-56.
[5]	刘元春, 郝志宏, 于力. 儿童肾病综合征红细胞分布宽度与肾功能损害的相关分析[J]. 广州医药, 2016, 47(3): 49-52.
[6]	朱秋云. 复方丹参注射液对轻度子痫前期患者肾功能及妊娠结局的影响[J]. 广州医药, 2015, 46(1): 10-12.